These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10723581)

  • 21. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation.
    Shaw BE; Arguello R; Garcia-Sepulveda CA; Madrigal JA
    Br J Haematol; 2010 Aug; 150(3):251-8. PubMed ID: 20560963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of HLA-DQA1 gene in the Korean population.
    Lee KW; Jung YA; Oh DH
    Tissue Antigens; 2007 Apr; 69 Suppl 1():82-4. PubMed ID: 17445173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of molecular analysis of HLA-A*02 subtyping for unrelated bone-marrow donor selection.
    Cecuk-Jelicić E; Grubić Z; Zunec R; Labar B; Kerhin-Brkljacić V; Kastelan A
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S27-30. PubMed ID: 9916628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population.
    Säilä H; Pitkäniemi J; Tuomilehto J; Savolainen A; Alakulppi N; Tuomilehto-Wolf E; Leirisalo-Repo M; Aho K
    J Rheumatol; 2004 Nov; 31(11):2281-5. PubMed ID: 15517645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA typing in the Japanese Bone Marrow Program].
    Akaza T
    Rinsho Byori; 1997 Feb; 45(2):157-60. PubMed ID: 9121000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of HLA genes for the selection of unrelated bone marrow donor.
    Mantovani V; Martinelli G; Bragliani M; Buzzi M; Selva P; Collina E; Farabegoli P; Rosti GA; Bandini G; Tura S
    Bone Marrow Transplant; 1995 Sep; 16(3):329-35. PubMed ID: 8535303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of unrelated bone marrow donors by PCR-SSP typing and subsequent nonradioactive sequence-based typing for HLA DRB1/3/4/5, DQB1, and DPB1 alleles.
    Knipper AJ; Hinney A; Schuch B; Enczmann J; Uhrberg M; Wernet P
    Tissue Antigens; 1994 Nov; 44(5):275-84. PubMed ID: 7878653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrelated donor matching for bone marrow transplantation.
    Chopek M; Alosco S; Salazar M; Yunis EJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1255-8. PubMed ID: 8442106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
    Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
    Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.
    Shaw BE; Potter MN; Mayor NP; Pay AL; Smith C; Goldman JM; Prentice HG; Marsh SG; Madrigal JA
    Bone Marrow Transplant; 2003 Jun; 31(11):1001-8. PubMed ID: 12774051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA DQ and DP locus mismatches and their effect on MLC in HLA class I- and DRB1-matched unrelated patient/donor pairs waiting for allogeneic bone-marrow transplantation.
    Partanen J; Koskimies S
    Scand J Immunol; 1994 Mar; 39(3):301-4. PubMed ID: 8128190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of HLA class II genes in Miao and Yao nationalities of Southwest China.
    Liu Y; Liu Z; Fu Y; Jia Z; Chen S; Xu A
    Tissue Antigens; 2006 Feb; 67(2):157-9. PubMed ID: 16441488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Polymorphism Analysis of HLA Class II Alleles Based on Next-Generation Sequencing and Prevention Strategy for Allele Dropout].
    Gao SQ; Quan ZR; Zhong YP; Chen H; He LM; Zou HY; Deng ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):603-609. PubMed ID: 38660873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class II allele and haplotype frequencies in Koreans based on 107 families.
    Song EY; Park MH; Kang SJ; Park HJ; Kim BC; Tokunaga K; Akaza T; Juji T
    Tissue Antigens; 2002 Jun; 59(6):475-86. PubMed ID: 12445317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations.
    Rufer N; Tiercy JM; Breur-Vriesendorp B; Gauchat-Feiss D; Shi X; Slavcev A; Lardy N; Speiser D; Gratwohl A; Chapuis B
    Bone Marrow Transplant; 1995 Nov; 16(5):641-6. PubMed ID: 8547860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class II allele and haplotype frequencies in Iranian patients with leukemia.
    Khosravi F; Amirzargar A; Sarafnejad A; Nicknam MH; Alimoghadam K; Dianat S; Solgi G; Nikbin B
    Iran J Allergy Asthma Immunol; 2007 Sep; 6(3):137-42. PubMed ID: 17893434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New strategies for selection of unrelated bone marrow donors.
    Martinelli G; Buzzi M; Farabegoli P; Testoni N; Mantovani V; Calori E; Rosti G; Bandini G; Bragliani M; Panzica G
    Bone Marrow Transplant; 1993; 11 Suppl 1():31-2. PubMed ID: 8448542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of NGS-based HLA 9-locus haplotypes in the Eastern Han Chinese population highlights the role of HLA-DP in donor selection for transplantation.
    Zhang T; Li Y; Yuan X; Bao X; Chen L; Jiang X; He J
    HLA; 2022 Dec; 100(6):582-596. PubMed ID: 36054323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
    J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.